MARENA WINDLE: Open Payments
NPI 1144993023 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,798 in 136 payments from 21 companies in 2025. Trend: 2023 $3,336 · 2024 $3,446 · 2025 $2,798
Food & beverage: $2,798
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $683 |
| ABBVIE INC. | 17 | $317 |
| Organon LLC | 7 | $220 |
| Arcutis Biotherapeutics, Inc. | 12 | $217 |
| UCB, Inc. | 12 | $217 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $193 |
| LEO Pharma Inc. | 10 | $179 |
| Lilly USA, LLC | 7 | $155 |
| Galderma Laboratories, L.P. | 22 | $147 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $73 |
Products named: Zoryve, Bimzelx, COSENTYX, Rhapsido, SKYRIZI, EBGLYSS, ADBRY, VTAMA.
Industry payments across AL — which companies pay providers there.
